260 related articles for article (PubMed ID: 9363700)
1. Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination.
Mercan R; Mayer JF; Walker D; Jones S; Oehninger S; Toner JP; Muasher SJ
Hum Reprod; 1997 Sep; 12(9):1886-9. PubMed ID: 9363700
[TBL] [Abstract][Full Text] [Related]
2. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
[TBL] [Abstract][Full Text] [Related]
3. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
[TBL] [Abstract][Full Text] [Related]
4. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
5. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin.
Imthurn B; Macas E; Rosselli M; Keller PJ
Hum Reprod; 1996 Nov; 11(11):2387-91. PubMed ID: 8981116
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization.
Daya S; Gunby J; Hughes EG; Collins JA; Sagle MA
Hum Reprod; 1995 Jun; 10(6):1392-6. PubMed ID: 7593503
[TBL] [Abstract][Full Text] [Related]
7. Serum follicle-stimulating hormone inhibition is a marker for preovulatory oocytes in in-vitro fertilization and embryo transfer.
Kreiner D; Itskovitz J; Droesch K; Navot D; Liu HC; Rosenwaks Z
Hum Reprod; 1989 May; 4(4):381-3. PubMed ID: 2501334
[TBL] [Abstract][Full Text] [Related]
8. An artificially induced follicle stimulating hormone surge at the time of human chorionic gonadotrophin administration in controlled ovarian stimulation cycles has no effect on cumulus expansion, fertilization rate, embryo quality and implantation rate.
Vermeiden JP; Roseboom TJ; Goverde AJ; Suchartwatnachai C; Schoute E; Braat DD; Schats R
Hum Reprod; 1997 Jul; 12(7):1399-402. PubMed ID: 9262265
[TBL] [Abstract][Full Text] [Related]
9. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
[TBL] [Abstract][Full Text] [Related]
10. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone.
Sills ES; Schattman GL; Veeck LL; Liu HC; Prasad M; Rosenwaks Z
Fertil Steril; 1998 May; 69(5):831-5. PubMed ID: 9591488
[TBL] [Abstract][Full Text] [Related]
12. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z
Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087
[TBL] [Abstract][Full Text] [Related]
13. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
[TBL] [Abstract][Full Text] [Related]
14. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
15. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Dahan MH; Agdi M; Shehata F; Son W; Tan SL
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer.
Kreiner D; Droesch K; Itskovitz J; Liu HC; Navot D; Rosenwaks Z
J In Vitro Fert Embryo Transf; 1988 Oct; 5(5):265-7. PubMed ID: 3148022
[TBL] [Abstract][Full Text] [Related]
17. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome.
Strehler E; Abt M; El-Danasouri I; De Santo M; Sterzik K
Fertil Steril; 2001 Feb; 75(2):332-6. PubMed ID: 11172835
[TBL] [Abstract][Full Text] [Related]
18. The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.
Muasher SJ; Garcia JE; Rosenwaks Z
Fertil Steril; 1985 Jul; 44(1):62-9. PubMed ID: 3924669
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme.
Söderström-Anttila V; Foudila T; Hovatta O
Hum Reprod; 1996 Sep; 11(9):1864-70. PubMed ID: 8921055
[TBL] [Abstract][Full Text] [Related]
20. Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone.
Jacob S; Drudy L; Conroy R; Harrison RF
Hum Reprod; 1998 Jul; 13(7):1783-7. PubMed ID: 9740423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
